• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 血清转化的注射吸毒者中艾滋病的疾病进展及早期预测因素。意大利血清转化研究。

Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users. The Italian Seroconversion Study.

出版信息

AIDS. 1992 Apr;6(4):421-6.

PMID:1616637
Abstract

OBJECTIVE

To evaluate the risk of developing AIDS and to identify early markers of disease progression in injecting drug users (IDU).

DESIGN

Prospective study.

SETTING

Sixteen centres throughout Italy.

PATIENTS, PARTICIPANTS: Four hundred and sixty-eight IDU for whom it was possible to estimate the date of HIV seroconversion.

MAIN OUTCOME MEASURES

Progression to AIDS.

RESULTS

Twenty-six subjects developed AIDS during a median follow-up period of 42 months. The risk of developing AIDS was 21% within 7 years following seroconversion. Age greater than 25 years at seroconversion was associated with more rapid disease progression. Progression was similar for men and women. Continued drug injection did not accelerate progression to AIDS. Among the laboratory markers studied, CD4+ cell count at the first HIV-positive test was the best predictor of disease progression. Results were confirmed using multivariate analysis.

CONCLUSIONS

Our findings indicate the importance of the role played by age in accelerated disease progression, which may be determined by a more rapid decline in CD4+ cell number in older HIV-infected IDU.

摘要

目的

评估注射吸毒者(IDU)患艾滋病的风险,并确定疾病进展的早期标志物。

设计

前瞻性研究。

地点

意大利全国16个中心。

患者、参与者:468名IDU,其HIV血清转化日期可估算。

主要观察指标

进展为艾滋病。

结果

在中位随访期42个月内,26名受试者发展为艾滋病。血清转化后7年内患艾滋病的风险为21%。血清转化时年龄大于25岁与疾病进展更快相关。男性和女性的进展情况相似。持续注射毒品并未加速进展为艾滋病。在所研究的实验室标志物中,首次HIV检测呈阳性时的CD4+细胞计数是疾病进展的最佳预测指标。多因素分析证实了结果。

结论

我们的研究结果表明年龄在加速疾病进展中所起作用的重要性,这可能是由老年HIV感染IDU中CD4+细胞数量更快下降所决定的。

相似文献

1
Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users. The Italian Seroconversion Study.HIV 血清转化的注射吸毒者中艾滋病的疾病进展及早期预测因素。意大利血清转化研究。
AIDS. 1992 Apr;6(4):421-6.
2
Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.艾滋病进展的免疫标志物:五个艾滋病毒感染队列的一致性。多队列分析项目研讨会。第一部分。
AIDS. 1994 Jul;8(7):911-21.
3
Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.血清转化的免疫标志物途径:单次测定免疫球蛋白A和β2-微球蛋白不足以估计HIV感染时间。多队列分析项目研讨会。第二部分。
AIDS. 1994 Jul;8(7):923-33.
4
Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.注射吸毒者中艾滋病毒感染的进展:频繁借用注射器具者进展率较低的迹象。
AIDS. 1993 Oct;7(10):1363-70.
5
CD4 surveillance in Scotland: perspectives on severe HIV-related immunodeficiency. CD4 Collaborative Group.苏格兰的CD4监测:关于严重HIV相关免疫缺陷的观点。CD4协作组。
AIDS. 1997 Oct;11(12):1509-17.
6
Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.1986年至2001年一组注射吸毒者中从HIV血清转化发展为艾滋病及死亡的性别差异。
J Epidemiol Community Health. 2004 Nov;58(11):944-50. doi: 10.1136/jech.2003.017475.
7
[Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].[一组智利患者中人类免疫缺陷病毒感染的自然史]
Rev Med Chil. 1996 May;124(5):525-35.
8
[Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].[高效抗逆转录病毒疗法(HAART)引入前后HIV阳性个体的生存情况、进展为艾滋病及免疫抑制情况]
Epidemiol Prev. 2003 Nov-Dec;27(6):348-55.
9
Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.蒙特利尔和多伦多注射吸毒者中HIV-1感染的血清流行率及危险因素:一项合作研究。
CMAJ. 1993 Oct 1;149(7):945-51.
10
Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men.HIV-1血清转化者疾病进展标志物的变化:注射吸毒者队列与男同性恋者队列的比较。
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 1;8(1):66-74.

引用本文的文献

1
MODELING LEFT-TRUNCATED AND RIGHT-CENSORED SURVIVAL DATA WITH LONGITUDINAL COVARIATES.使用纵向协变量对左截断和右删失生存数据进行建模。
Ann Stat. 2012 Jun;40(3):1465-1488. doi: 10.1214/12-AOS996. Epub 2012 Sep 5.
2
Accounting for dropout reason in longitudinal studies with nonignorable dropout.在存在不可忽视的失访情况的纵向研究中考虑失访原因。
Stat Methods Med Res. 2017 Aug;26(4):1854-1866. doi: 10.1177/0962280215590432. Epub 2015 Jun 15.
3
The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use.
在高效抗逆转录病毒治疗时代,一组HIV血清阳性女性中,非注射吸毒行为与艾滋病进展及死亡之间的关系。
Addiction. 2005 Jul;100(7):990-1002. doi: 10.1111/j.1360-0443.2005.01098.x.
4
Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997.体重减轻和体重指数作为成人HIV疾病进展至艾滋病的预测指标。法国阿基坦队列研究,1985 - 1997年。
J Am Coll Nutr. 2001 Dec;20(6):609-15. doi: 10.1080/07315724.2001.10719065.
5
Serum IgG antibodies to human herpesvirus-6 (HHV-6) do not predict the progression of HIV disease to AIDS. Italian Seroconversion Study group.针对人类疱疹病毒6型(HHV - 6)的血清IgG抗体不能预测HIV疾病进展为艾滋病。意大利血清转化研究组。
Eur J Epidemiol. 1999 Apr;15(4):317-22. doi: 10.1023/a:1007503018729.
6
Estimating the size of the HIV epidemic among injecting drug users in Amsterdam.估算阿姆斯特丹注射吸毒者中艾滋病病毒的流行规模。
Eur J Epidemiol. 1997 Apr;13(3):261-5. doi: 10.1023/a:1007346800071.
7
Improving the prognostic value of CD4+ count using IgA and clinical signs in HIV-seropositive i.v. drug users.利用IgA和临床体征提高HIV血清阳性静脉注射吸毒者CD4+细胞计数的预后价值。
Infection. 1997 Mar-Apr;25(2):117-20. doi: 10.1007/BF02113591.
8
Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 10(6)/l, AIDS, and death from AIDS?有症状的原发性HIV-1感染是否会加速疾病进展至美国疾病控制与预防中心(CDC)IV期、CD4细胞计数低于200×10⁶/L、获得性免疫缺陷综合征(AIDS)以及死于AIDS?
BMJ. 1994 Dec 10;309(6968):1535-7. doi: 10.1136/bmj.309.6968.1535.